When to consider left atrial appendage occlusion

28 August 2026 (11:00 - 11:15)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)

3 More presentations in this session

Presentation thumbnail

Personalised antithrombotic therapy after atrial fibrillation ablation

Professor R. Schnabel (Hamburg, DE)

Presentation thumbnail

Can we stop anticoagulation after successful atrial fibrillation ablation?

Doctor V. Markides (London, GB)

Presentation thumbnail

Novel antithrombotic strategies in atrial fibrillation: time to personalise? - patient perspective

Mr M. Madigan (Dublin, IE)

Access the full session

Session thumbnail

Challenges with antithrombotic strategies in atrial fibrillation and coronary disease: time to personalise?

The Event

Event poster

ESC Congress 2026

28 August 2026 11:00 CET

You may be interested in

Congress Presentation

Left atrial appendage closure in anticoagulant-eligible patients with atrial fibrillation: con

31 August 2025

Congress Presentation

Reduced-dose direct oral anticoagulation vs antiplatelet strategies after left atrial appendage occlusion in atrial fibrillation. a triple target trial emulation from a federated research network

29 August 2026

Congress Presentation

What is the optimal anticoagulation/antiplatelet strategy following left atrial appendage closure?

12 April 2026

Congress Presentation

Left atrial appendage occlusion in cancer patients with atrial fibrillation: closing the gap in stroke prevention

29 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources